Global Regulatory Issues For The Cosmetics Industry

This volume examines regulatory issues of ingredients, manufacturing, and finished products, as well as claim substantiation, packaging, and advertising. A chapter on Chinese regulations will be one of the first about this country to be published in book form. • Includes a regulatory map of India and China • Global IP protection strategies • REACH and European Regulatory standards • "Green chemistry" in relation to cosmetics and regulation * Simplifies global regulations for anyone exporting cosmetics. * Excellent reference not only for manufacturing and marketing, but for legal departments and packaging as well. * Describes how to develop a global regulatory strategy.

Global Regulatory Issues for the Cosmetics Industry, Volume 1, emerged from the first annual Cosmetic Regulatory Forum organized by Health and Beauty America (HBA) in September 2006. It is the first of an annual book mini-series surveying issues in this critical and rapidly changing area. These changes affect the health, safety, and well-being of literally billions of consumers, their governments, and the corporations involved in the prodigious task of not only creating novel, effective and safe products, but also complying with regulations, that vary from country to country. This book begins with a discussion of the risks assessment of cosmetic products. This is followed by separate chapters on the regulatory system in some of the major export markets of Canada and Australasia; the evolution and purpose of the EU's REACH (Registration, Evaluation, Authorization of Chemicals); the issue of cosmetic toxicity; and regulatory requirements and warnings for cosmetic products. Subsequent chapters cover the challenges of global chemical compliance; the development of nanotechnology-based products and their potential impact on human health and the environment; and the various packaging regulations relating to colors and additives for products marketed in North America, the EU, and Asia.

This book summarizes the authority of regulatory agencies and programs as they pertain to the cosmetic industry, offers practical advice on how to operate within the regulatory environment, and introduces scientific and regulatory issues that are likely to have an impact on cosmetic manufacturers. "This interesting volume reports all the novel technologies in use to study and control the cosmetic products in order to make them effective and free of side effects." ---Journal of Applied Cosmetology, 2000

The new 9th edition of Harry's Cosmeticology is available as a 3 volume set containing over 2600 pages of new information on the recent changes in the cosmetic and personal care industry. Chemical Publishing is now offering key parts of the title for those interested in a particular subject area covered in the book. Harry's Cosmeticology 9th Edition has developed a new line of "Focus Books" for this purpose. Focus books are a series of selected chapters that can be used as a reference guide for a particular subject area. This focus book covers: Achieving Global Cosmetic Market Access: Issues and Approaches (Harrys Cosmeticology 9th Ed.) Part 2.1 Regulatory Requirements, Intellectual Property and Achieving Global Market Success for Cosmetic Products (by Co-Editors Ruud Overbeek of Intertek and Meyer R. Rosen) - Part 2.2 An Overview of the Changing Regulatory Landscape in the U.S and the E.U. and how to Deal with them (by Dr. Matteo Zanotti Russo of Angel Consulting SAS Milano) - Part 2.3.1 Achieving Global Market Access: Focus on Russia (by Ramzia Lefebvre Technical Manager for Russia and Customs Union, Certification, Intertek France: Government & Trade Services) - Part 2.3.2 Kingdom of Saudi Arabia (KSA): Cosmetics and Perfumery Products: Market Access and Regulations (by Ms. Aurlie Bafoil Cosmetic Regulatory Affairs Senior Analyst, Intertek Government and Trade Services) - Part 2.3.3 Achieving Global Market Access: Focus on China by (Mr. Zhongrui Li "Mr. Ray Li" Toxicological Risk Assessor) - Part 2.3.4 Nanomaterials in Cosmetics: Regulatory and Safety Considerations (by Jeffrey W. Card Ph.D. and Tomas Jonaitis Senior Program Manager, Toxicology Pharmaceuticals & Healthcare) - Part 2.4 Intellectual Property (IP) Issues: Patents and Trade Secrets (by Charles Brumlik, J.D., Ph.D.)